Actively Recruiting
Role of the Immune Environment in Response to Therapy in Breast Cancer
Led by Abramson Cancer Center at Penn Medicine · Updated on 2025-07-08
300
Participants Needed
1
Research Sites
534 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is an observational case-control study of tissues collected from women with ER+HER2- breast cancers. The immune environments of these cancers will be compared to triple negative and HER2+ breast cancers. No randomization or changes to standard of care treatment will occur as part of the study.
CONDITIONS
Official Title
Role of the Immune Environment in Response to Therapy in Breast Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women 18 years of age or older with non-metastatic breast cancer
- Undergoing surgical resection at the University of Pennsylvania Health System
You will not qualify if you...
- Male individuals
- Children
- Pregnant individuals
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Abramson Cancer Center
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
Research Team
J
Julia T. Lewandowski
CONTACT
J
Jennifer Zhang, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here